+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

From
From
Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Hepatitis B Vaccine Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Hepatitis B Vaccine Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 146 Pages
  • Global
From
From
From
From
From
From
From
Chikungunya - Pipeline Insight, 2025 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Marburg Virus Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Marburg Virus Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Anthrax - Pipeline Insight, 2025 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator